BioCentury
ARTICLE | Company News

Circassia, NanoPass Technologies deal

September 19, 2011 7:00 AM UTC

Circassia received rights to NanoPass' MicronJet microneedle intradermal delivery device for use in allergy vaccine indications. Terms were not disclosed. Circassia is developing allergy vaccines that...